Frederick J. Raal

Johannesburg, GT, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 247 publications

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.

Journal: Journal of lipid research

Published: June 13, 2026

New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering.

New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering.

Journal: Circulation research

Published: June 04, 2026

Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement.

Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement.

Journal: European heart journal

Published: May 25, 2026

Andes virus associated hantavirus cardiopulmonary syndrome and repurposing lipid medications to calm down the cytokine storm.

Andes virus associated hantavirus cardiopulmonary syndrome and repurposing lipid medications to calm down the cytokine storm.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: May 24, 2026

Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia: A Nonrandomized Clinical Trial.

Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia: A Nonrandomized Clinical Trial.

Journal: JAMA cardiology

Published: April 29, 2026

Lipid-lowering therapy after finding high Lp(a)-adding ezetimibe or intensifying statin treatment?

Lipid-lowering therapy after finding high Lp(a)-adding ezetimibe or intensifying statin treatment?

Journal: Journal of clinical lipidology

Published: April 21, 2026

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

Journal: Atherosclerosis

Published: March 18, 2026

LDL-cholesterol targets and lipid-lowering therapies - a plea to medical schemes and the Council for Medical Schemes.

LDL-cholesterol targets and lipid-lowering therapies - a plea to medical schemes and the Council for Medical Schemes.

Journal: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Published: March 12, 2026

ANGPTL3-lowering strategies to address residual cardiovascular risk.

ANGPTL3-lowering strategies to address residual cardiovascular risk.

Journal: Nature reviews. Cardiology

Published: March 11, 2026

Liver transplantation in severe homozygous familial hypercholesterolaemia: a scoping review.

Liver transplantation in severe homozygous familial hypercholesterolaemia: a scoping review.

Journal: Atherosclerosis

Published: February 18, 2026

Challenges in the care of women with familial hypercholesterolaemia during the reproductive period - current evidence and practical guidance.

Challenges in the care of women with familial hypercholesterolaemia during the reproductive period - current evidence and practical guidance.

Journal: Atherosclerosis

Published: January 27, 2026

Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry.

Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry.

Journal: European heart journal

Published: January 12, 2026

Showing 1-12 of 247

Last Updated: 09/26/2026